Clinical trial
Fluvastatin Versus Hepatitis C Virus
NCT00441493 · Bader, Ted, M.D., Other · Completed
Key facts
| NCT number | NCT00441493 |
|---|---|
| Title | Fluvastatin Versus Hepatitis C Virus |
| Official title | A Dose Finding Study of Fluvastatin for in Vivo Demonstration of Inhibiting Hepatitis C Replication in Patients Infected With Chronic Hepatitis C With Special Attention to the African-American Population. |
| Lead sponsor | Bader, Ted, M.D., Other |
| Collaborators | US Department of Veterans Affairs U.S. Fed |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | fluvastatin |
| Enrollment | 32 |
| Start date | Sep 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Mar 1, 2007 |
| Last update posted | Jul 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: